Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antitumor effect and safety of clinical
effectiveness dendritic cell activated Cytokine induced killer treatment (DC-CIK) plus S-1
based chemotherapy for advanced gastric cancer.